Status:

COMPLETED

The Efficacy of Hypertonic Dextrose Injection to Anterior Talofibular Ligament Sprain

Lead Sponsor:

Taipei Medical University WanFang Hospital

Conditions:

Ankle Sprains

Eligibility:

All Genders

20-70 years

Phase:

NA

Brief Summary

Anterior talofibular ligament is the most injured ligament in ankle sprain. Investigators will include ankle sprain patients who have ankle pain or instability more than 3 months. Ultrasonography will...

Detailed Description

Background: Sprains constitute most of ankle injury and 85% ankle sprain is inversion injury. The conventional treatment includes medication, physical therapy, bracing and steroid injection. Anterior ...

Eligibility Criteria

Inclusion

  • 20-70 age
  • Chronic ankle sprain more than 3months with chronic ankle pain or instability sensation
  • Ultrasound diagnosed anterior talofibular ligament sprain

Exclusion

  • Acute ankle sprain less than 3 months
  • Lower limb fracture history
  • Cognitive impairment
  • Other neurological or muscular disorders
  • Sever pain could not tolerate examination

Key Trial Info

Start Date :

November 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2022

Estimated Enrollment :

29 Patients enrolled

Trial Details

Trial ID

NCT03868995

Start Date

November 1 2019

End Date

December 31 2022

Last Update

September 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Taipei medical university

Taipei, Taiwan, 116